Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches.

Recent epidemiological studies highlight the key role of the type of consumed unsaturated fatty acid and the development of ulcerative colitis (UC). We aimed to review the potential mechanisms behind the antiinflammatory effects of unsaturated fatty acids on intestinal inflammation, to discuss their potential limitations, and to propose a new reappraisal of polyunsaturated fatty acids (PUFAs) in the pathophysiology of inflammatory bowel disease (IBD). A literature search using PubMed was carried out to identify relevant studies (basic science, epidemiological studies, or clinical trials) with unsaturated fatty acids and IBD. Only articles published in English were included. IBD patients exhibit an altered lipid metabolism. While in vitro and in vivo studies have demonstrated the antiinflammatory properties of n-3 polyunsaturated fatty acids in experimental models IBD, results of clinical trials have been disappointing. In addition, the impact of fatty acid on innate immunity as an alternative therapeutic approach is explored. This may offer insight into therapeutic avenues for designing n-3 PUFA diet therapy for IBD.

[1]  J. Grogan,et al.  Enteral Feeding Therapy for Newly Diagnosed Pediatric Crohn's Disease: A Double‐Blind Randomized Controlled Trial with Two Years Follow‐Up§ , 2012, Inflammatory bowel diseases.

[2]  P. Déchelotte,et al.  Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium. , 2011, Clinical nutrition.

[3]  Christopher F. Martin,et al.  Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease 12 , 2011, Inflammatory bowel diseases.

[4]  H. Roche,et al.  Omega-3 fatty acids attenuate dendritic cell function via NF-κB independent of PPARγ. , 2011, The Journal of nutritional biochemistry.

[5]  A. Dolganiuc,et al.  Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells , 2011, Hepatology.

[6]  D. Oh,et al.  The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity , 2011, Current opinion in clinical nutrition and metabolic care.

[7]  Yan Li,et al.  NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis , 2011, Inflammatory bowel diseases.

[8]  O. Leavy.  Innate immunity: Linking lipids and inflammasomes , 2011, Nature Reviews Immunology.

[9]  Richard A. Flavell,et al.  NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.

[10]  S. Young,et al.  Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. , 2011, Cell metabolism.

[11]  A. Kaser,et al.  Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. , 2011, Gastroenterology.

[12]  Denis Gris,et al.  Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling , 2011, Nature Immunology.

[13]  J. Haeggström,et al.  Leukotriene B4/antimicrobial peptide LL‐37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  J. Hibbeln,et al.  Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. , 2011, The American journal of clinical nutrition.

[15]  M. Hull,et al.  Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer , 2011, Gut.

[16]  Ping Zhang,et al.  Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity , 2011, Nature Medicine.

[17]  H. El‐Serag,et al.  Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature , 2011, The American Journal of Gastroenterology.

[18]  F. Fava,et al.  Intestinal microbiota in inflammatory bowel disease: friend of foe? , 2011, World journal of gastroenterology.

[19]  P. Siersema,et al.  Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease , 2011, Gut.

[20]  U. Vogel,et al.  Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease. , 2011, World journal of gastroenterology.

[21]  H. Meltzer,et al.  Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index – a pilot study , 2011, Scandinavian journal of clinical and laboratory investigation.

[22]  A. Griffiths,et al.  Maintenance of remission in inflammatory bowel disease using omega‐3 fatty acids (fish oil): A systematic review and meta‐analyses , 2011, Inflammatory bowel diseases.

[23]  J. Vinel,et al.  Transient receptor potential vanilloid 4 activated inflammatory signals by intestinal epithelial cells and colitis in mice. , 2011, Gastroenterology.

[24]  A. Tjønneland,et al.  An association between dietary arachidonic acid, measured in adipose tissue, and ulcerative colitis. , 2010, Gastroenterology.

[25]  J. Sanderson,et al.  Probiotic and prebiotic use in patients with inflammatory bowel disease: A case‐control study† , 2010, Inflammatory bowel diseases.

[26]  G. Zaloga,et al.  Oleic acid inhibits stearic acid-induced inhibition of cell growth and pro-inflammatory responses in human aortic endothelial cells , 2010, Journal of Lipid Research.

[27]  M. Brito,et al.  Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgamma apoptotic genes in modulating Crohn's disease activity. , 2010, Clinical nutrition.

[28]  J. Achkar,et al.  Pathogenesis of postoperative recurrence in Crohn's disease , 2010, Gut.

[29]  K. Nones,et al.  Diversity of caecal bacteria is altered in interleukin-10 gene-deficient mice before and after colitis onset and when fed polyunsaturated fatty acids. , 2010, Microbiology.

[30]  J. Achkar,et al.  ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. , 2010, Gastroenterology.

[31]  M. Oosting,et al.  Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. , 2010, Arthritis and rheumatism.

[32]  A. Lichtenstein,et al.  Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. , 2010, The Journal of nutrition.

[33]  J. Cooney,et al.  Dietary oleic acid as a control fatty acid for polyunsaturated fatty acid intervention studies: a transcriptomics and proteomics investigation using interleukin-10 gene-deficient mice. , 2010, Biotechnology journal.

[34]  R. Kawamori,et al.  Free fatty acids stimulate autophagy in pancreatic β-cells via JNK pathway. , 2010, Biochemical and biophysical research communications.

[35]  J. Fenton,et al.  Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis. , 2010, Cancer research.

[36]  J. Kang,et al.  A decreased n-6/n-3 ratio in the fat-1 mouse is associated with improved glucose tolerance. , 2010, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[37]  E. Murphy,et al.  Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models , 2010, Gut.

[38]  H. Tajiri,et al.  N‐3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease , 2010, Inflammatory bowel diseases.

[39]  S. Yoo,et al.  Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti‐nociception , 2010, British journal of pharmacology.

[40]  F. Clavel-Chapelon,et al.  Animal Protein Intake and Risk of Inflammatory Bowel Disease: The E3N Prospective Study , 2010, The American Journal of Gastroenterology.

[41]  P. Déchelotte,et al.  An α-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-κB in rats with TNBS-induced colitis. , 2010, The Journal of nutrition.

[42]  S. Watkins,et al.  GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects , 2010, Cell.

[43]  B. Bertin,et al.  Obesity, visceral fat and Crohn's disease , 2010, Current opinion in clinical nutrition and metabolic care.

[44]  C. McClain,et al.  Inactivation of hepatocyte nuclear factor-4{alpha} mediates alcohol-induced downregulation of intestinal tight junction proteins. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[45]  J. Nicholson,et al.  Dietary modulation of gut functional ecology studied by fecal metabonomics. , 2010, Journal of proteome research.

[46]  J. J. Moreno,et al.  Role of eicosanoids on intestinal epithelial homeostasis. , 2010, Biochemical pharmacology.

[47]  S. Massart,et al.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa , 2010, Proceedings of the National Academy of Sciences.

[48]  Yan Li,et al.  Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome. , 2010, Gastroenterology.

[49]  J. Rutledge,et al.  Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[50]  T. Merriman,et al.  Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease , 2010, Genes and Immunity.

[51]  T. Nishinaka,et al.  Antinociceptive effects of docosahexaenoic acid against various pain stimuli in mice. , 2010, Biological & pharmaceutical bulletin.

[52]  P. Anand,et al.  Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain , 2010, Gut.

[53]  R. Luben,et al.  Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study , 2010, European journal of gastroenterology & hepatology.

[54]  N. Roy,et al.  Dietary arachidonic acid-mediated effects on colon inflammation using transcriptome analysis. , 2010, Molecular nutrition & food research.

[55]  M. Chamaillard,et al.  Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon , 2010, Proceedings of the National Academy of Sciences.

[56]  Elke Cario,et al.  Toll-like receptors in inflammatory bowel diseases: A decade later , 2010, Inflammatory bowel diseases.

[57]  R. Luben,et al.  100 Dietary Oleic Acid Protects Against the Development of Ulcerative Colitis – A UK Prospective Cohort Study Using Data From Food Diaries , 2010 .

[58]  A. Cheifetz,et al.  Meta‐analysis: targeting the intestinal microbiota in prophylaxis for post‐operative Crohn’s disease , 2010, Alimentary pharmacology & therapeutics.

[59]  M. Kastan,et al.  The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. , 2010, Immunity.

[60]  Takuya Suzuki,et al.  Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats , 2010, Nutrition & metabolism.

[61]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[62]  G. Radford-Smith,et al.  Role of diet in the development of inflammatory bowel disease , 2010, Inflammatory bowel diseases.

[63]  L. Blackshaw,et al.  TRP channels: new targets for visceral pain , 2009, Gut.

[64]  D. Corey,et al.  The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli. , 2009, Gastroenterology.

[65]  A. Cheifetz,et al.  Interventions for prevention of post-operative recurrence of Crohn's disease. , 2009, The Cochrane database of systematic reviews.

[66]  A. Houllier,et al.  Hepatocyte Nuclear Factor 4α, a Key Factor for Homeostasis, Cell Architecture, and Barrier Function of the Adult Intestinal Epithelium , 2009, Molecular and Cellular Biology.

[67]  M. Brito,et al.  Fatty Acids, IL6, and TNFα Polymorphisms: An Example of Nutrigenetics in Crohn's Disease , 2009, The American Journal of Gastroenterology.

[68]  J. Jansson,et al.  Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease , 2009, PloS one.

[69]  E. Riboli,et al.  Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case–control study within a European prospective cohort study , 2009, Gut.

[70]  Eugene Bolotin,et al.  Identification of an Endogenous Ligand Bound to a Native Orphan Nuclear Receptor , 2009, PloS one.

[71]  M. Sans,et al.  VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. , 2009, Gastroenterology.

[72]  C. Buechler,et al.  Fatty acid‐induced induction of Toll‐like receptor‐4/nuclear factor‐κB pathway in adipocytes links nutritional signalling with innate immunity , 2009, Immunology.

[73]  Kenji Suzuki,et al.  Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis? , 2008, Journal of gastroenterology and hepatology.

[74]  S. Miura,et al.  Omega‐3 fatty acids exacerbate DSS‐induced colitis through decreased adiponectin in colonic subepithelial myofibroblasts , 2008, Inflammatory bowel diseases.

[75]  M. Eshraghian,et al.  THE EFFECT OF DIETARY OILS ON MICROFLORA IN EXPERIMENTAL COLITIS IN MICE , 2008 .

[76]  Subrata Ghosh,et al.  Is rosiglitazone a promising treatment for ulcerative colitis? , 2008, Nature Clinical Practice Gastroenterology &Hepatology.

[77]  J. Inoue,et al.  PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestine. , 2008, Biochemical and biophysical research communications.

[78]  K. Nagashima,et al.  Hepatocyte nuclear factor 4&agr; in the intestinal epithelial cells protects against inflammatory bowel disease , 2008, Inflammatory bowel diseases.

[79]  B. Stahl,et al.  Polyunsaturated fatty acids support epithelial barrier integrity and reduce IL-4 mediated permeability in vitro , 2008, European journal of nutrition.

[80]  A. Cohen,et al.  Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. , 2008, JAMA.

[81]  D. S. Le,et al.  Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease. , 2008, Nutrition research.

[82]  R. Playford,et al.  Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation. , 2008, The American journal of clinical nutrition.

[83]  J. Tschopp,et al.  The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response , 2008, Nature.

[84]  J. Ellenberg,et al.  Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. , 2008, Gastroenterology.

[85]  M. Wang,et al.  n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines. , 2008, Molecular immunology.

[86]  G. Schmitz,et al.  The opposing effects of n-3 and n-6 fatty acids. , 2008, Progress in lipid research.

[87]  A. Hekmatdoost,et al.  The effect of dietary oils on cecal microflora in experimental colitis in mice. , 2008, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[88]  D. Hommes,et al.  Fish oil for induction of remission in ulcerative colitis. , 2007, The Cochrane database of systematic reviews.

[89]  Lawrence A Leiter,et al.  Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. , 2007, The American journal of clinical nutrition.

[90]  Johan Auwerx,et al.  LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease , 2007, Proceedings of the National Academy of Sciences.

[91]  R. Mensink,et al.  Arachidonic Acid but not Eicosapentaenoic Acid (EPA) and Oleic Acid Activates NF-κB and Elevates ICAM-1 Expression in Caco-2 Cells , 2007, Lipids.

[92]  Daniel R. Jeske,et al.  Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. , 2007, Gastroenterology.

[93]  K. Weylandt,et al.  Lipoxins and resolvins in inflammatory bowel disease. , 2007, Inflammatory bowel diseases.

[94]  Ignacio Lizasoain,et al.  The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. , 2007, Gastroenterology.

[95]  K. Fukase,et al.  Differential Modulation of Nods Signaling Pathways by Fatty Acids in Human Colonic Epithelial HCT116 Cells* , 2007, Journal of Biological Chemistry.

[96]  M. Caplan,et al.  Polyunsaturated Fatty Acid Supplementation Alters Proinflammatory Gene Expression and Reduces the Incidence of Necrotizing Enterocolitis in a Neonatal Rat Model , 2007, Pediatric Research.

[97]  Charles N. Serhan,et al.  Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation1 , 2007, The Journal of Immunology.

[98]  G. Ahern,et al.  TRPV1 is a novel target for omega‐3 polyunsaturated fatty acids , 2007, The Journal of physiology.

[99]  Jifeng Zhang,et al.  Nitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators* , 2006, Journal of Biological Chemistry.

[100]  J. Nicholson,et al.  Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. , 2006, Physiological genomics.

[101]  M. Chamaillard,et al.  Mesenteric fat in Crohn’s disease: a pathogenetic hallmark or an innocent bystander? , 2006, Gut.

[102]  B. Blumberg,et al.  Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. , 2006, The Journal of clinical investigation.

[103]  K. Weylandt,et al.  Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[104]  J. Mary,et al.  Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial , 2005, Gut.

[105]  R. Strieter,et al.  CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer , 2006, The Journal of experimental medicine.

[106]  P. Calder,et al.  Fish oil alters T-lymphocyte proliferation and macrophage responses in Walker 256 tumor-bearing rats. , 2006, Nutrition.

[107]  S. O'keefe,et al.  Dietary fatty acids modulate chronic colitis, colitis-associated colon neoplasia and COX-2 expression in IL-10 knockout mice. , 2006, Nutrition.

[108]  T. Langmann,et al.  Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. , 2006, Biochimica et biophysica acta.

[109]  Makoto Arita,et al.  Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[110]  Danielle G. Lemay,et al.  Mediated through TLR4 Reciprocally Modulate Dendritic Cell Functions Saturated and Polyunsaturated Fatty Acids , 2012 .

[111]  M. Comalada,et al.  Biochemical and Molecular Actions of Nutrients Dietary Olive Oil Supplemented with Fish Oil , Rich in EPA and DHA ( n-3 ) Polyunsaturated Fatty Acids , Attenuates Colonic Inflammation in Rats with DSS-Induced Colitis 1 , 2005 .

[112]  Jifeng Zhang,et al.  Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor γ ligand , 2005 .

[113]  C. Moskaluk,et al.  Linkage to peroxisome proliferator-activated receptor-gamma in SAMP1/YitFc mice and in human Crohn's disease. , 2005, Gastroenterology.

[114]  Y. Bossé,et al.  The peroxisome proliferator-activated receptor alpha Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men. , 2005, The American journal of clinical nutrition.

[115]  Jifeng Zhang,et al.  Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[116]  J. Xaus,et al.  Inflammatory bowel , 2005 .

[117]  M. Pearce,et al.  Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study , 2004, Gut.

[118]  J. Bassaganya-Riera,et al.  Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease , 2004 .

[119]  J. Bassaganya-Riera,et al.  Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. , 2004, Gastroenterology.

[120]  Johan Auwerx,et al.  Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis , 2003 .

[121]  D. Hwang,et al.  Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. , 2003, Journal of lipid research.

[122]  A. Munakata,et al.  Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial , 2003, European journal of gastroenterology & hepatology.

[123]  M. Gassull,et al.  The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes. , 2003, Clinical nutrition.

[124]  J. Auwerx,et al.  Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. , 2003, Gastroenterology.

[125]  P. Calder,et al.  The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. , 2002, The American journal of clinical nutrition.

[126]  C. Richart,et al.  Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial , 2002, Gut.

[127]  A. Young,et al.  Lipoxin A4 Analogs Attenuate Induction of Intestinal Epithelial Proinflammatory Gene Expression and Reduce the Severity of Dextran Sodium Sulfate-Induced Colitis1 , 2002, The Journal of Immunology.

[128]  A. Sher,et al.  Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity , 2002, Nature Immunology.

[129]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[130]  I. Singer,et al.  Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. , 1998, Gastroenterology.

[131]  Peter J. Brown,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .

[132]  J. Lehmann,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[133]  S. Yamato,et al.  Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. , 1996, The American journal of clinical nutrition.

[134]  E. Collie-Duguid,et al.  Inhibitory effect of fish oil N-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. , 1996, Biochemical and biophysical research communications.

[135]  T. Toyota,et al.  Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease. , 1995, Scandinavian journal of gastroenterology.

[136]  M. Fujishima,et al.  Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. , 1987, Gut.

[137]  W. Stenson,et al.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. , 1984, Gastroenterology.

[138]  M. Ligumsky,et al.  Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel. , 1982, Gastroenterology.

[139]  U. Zor,et al.  Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. , 1978, Gastroenterology.